Home/Filings/4/0001181431-12-016291
4//SEC Filing

Prokocimer Philippe 4

Accession 0001181431-12-016291

CIK 0001356857other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 3:06 PM ET

Size

5.1 KB

Accession

0001181431-12-016291

Insider Transaction Report

Form 4
Period: 2012-03-08
Prokocimer Philippe
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2012-03-08+90,00090,000 total
    Exercise: $4.80Exp: 2022-03-07Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]The option vests in 48 successive equal monthly installments over the four year period beginning on March 8, 2012.

Issuer

Trius Therapeutics Inc

CIK 0001356857

Entity typeother

Related Parties

1
  • filerCIK 0001479790

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 3:06 PM ET
Size
5.1 KB